Christine Crish
Has grant
Associate Professor (tenured)
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
About
Christine Crish is an Assistant Professor at Northeast Ohio Medical University in the United States. Her research primarily focuses on topics related to neurobiology, bone remodeling, and histomorphogenesis, as evidenced by her recent publications. Notable articles include investigations into irisin treatment effects on tau levels in pre-symptomatic mice and bone remodeling in the naked mole-rat, highlighting her expertise in comparative biology and metabolic processes.
Recent Grants
Grant: Close
Fingolimod as a neuroprotectant against visual system pathology in Alzheimer's disease
Open Date: 2019-07-01
Close Date: 2019-09-01
Grant: Close
Visual system dysfunction in Alzheimer's disease
Open Date: 2018-01-01
Close Date: 2019-01-01
Grant: Close
Disruption of sensory pathways in dementia pathogenesis
Open Date:
Close Date:
Grant: Close
Linking integrin dysfunction with tauopathy in a LOAD model
Open Date:
Close Date:
Articles (6)
There is growing interest in understanding the mechanisms underlying differences in cancer incidence among species (comparative oncology). The naked mole rat (NMR) is often referenced as “cancer resistant” and prior studies focused on identifying mechanisms explaining this. However, efforts to assess this in vivo have been limited. In this study, we provide evidence that the NMR presents as a novel autochthonous model of lung tumor initiation, driven by an introduction of the oncogenic Eml4-Alk fusion gene using CRISPR-mediated genome editing. Although in mice, the inversion alone is sufficient to drive tumorigenesis, the inversion alone was insufficient to drive tumorigenesis in the NMR lung, and tumor development required additional losses of the tumor suppressors p53 and pRb. Our findings suggest that the proposed “resistance” of the NMR to the development of cancer may reflect that the genetic events leading to tumor initiation are likely to be comparable with those present in human cells. Significance: To identify evolutionary divergent mechanisms of cancer resistance, we assessed tumorigenesis in vivo using the NMR, a species considered to exhibit cancer resistance. Our findings suggest that the proposed “resistance” of NMRs to the development of cancer may reflect tumor initiation mechanisms comparable with the mechanisms present in humans. See related commentary by Boddy and Abegglen, p. 7
Year:
2026
Year:
2025
Year:
2025
Year:
2021
Year:
2021
Year:
2021
Collaborators (7)
Walid Khaled
University lecturer
University of Cambridge
Thomas Park
Professor
University of Chicago
Andrea Ventura
Member
Memorial Sloan Kettering Cancer Center
Woo Shik Shin
Northeast Ohio Medical University
Ewan Smith
Head of Department
University of Cambridge
Elsa Flores
Associate Center Director, Basic Science
H Lee Moffitt Cancer Center and Research Institute
Kenneth Tsai
Vice Chair of Research, Senior Member
H Lee Moffitt Cancer Center and Research Institute
Make your next move.
Prepare your application
Review drafts before you send them.